Evidence Level
Coconut oil research is polarized between metabolic benefits from MCTs and cardiovascular concerns from saturated fat. Reger et al. (2004) demonstrated that MCT administration acutely improved cognitive performance in memory-impaired patients, with effects correlating to plasma ketone levels — the primary mechanism underlying coconut oil's brain health claims. St-Onge & Jones (2002) showed MCTs increase energy expenditure and fat oxidation compared to long-chain fats, supporting thermogenic benefits. Cardoso et al. (2015) meta-analyzed coconut oil's lipid effects, confirming it significantly raises both HDL and LDL cholesterol compared to other cooking oils. The AHA's 2017 Presidential Advisory recommended against coconut oil due to LDL increases, while critics note the HDL increase may improve the total cholesterol-to-HDL ratio. Lauric acid's antimicrobial properties are well-documented in vitro, though clinical translation to infection prevention is limited. The key distinction is that coconut oil contains roughly 50% lauric acid (C12), which some researchers classify as a long-chain rather than medium-chain fatty acid due to its mixed metabolic behavior. Pure MCT oil (C8+C10) produces ketones more efficiently. For supplementation, the evidence supports cognitive and energy benefits from MCT content, but cardiovascular effects remain genuinely controversial.